- Joined
- Jan 5, 2019
- Messages
- 59
- Reaction score
- 107
I'm also a M2 at Drexel and I totally agree with everything Drake said.
Honestly, I think preclinical years at Drexel aren't that different from other MD programs. However, clinical site lottery can be a very stressful process for a lot of us. We just got our lottery results last week, and there are many classmates who didn't get a regional campus spot and have to move every few weeks to rotate between different sites for the third year.
Like Drake mentioned, one of our biggest rotation site in Philadelphia (which takes about 40 students/class), Crozer Health, is looking to sell its hospitals on the market right now. If they can't find a potential buyer by the end of this year, the hospital may be forced to shut down by its parent company, just like what happened to Hahnemann. Our primary clinical partner Tower Health is also struggling financially, and may be sold to private equity if it runs out of cash (it only has 30-day cash in hands right now according to Philadelphia Inquirer - a local newspaper.) Of course, these are not Drexel's faults since Drexel doesn't run any of these hospitals but rather only maintains loose affiliative relationship with them. However, if we do lose either clinical site, it can cause a lot of uncertainties to students, especially if they are shut down or being sold to a third-party in the middle of a rotation.
With that being said, I think admins at COM have realized what's going on at Crozer, which is why they announced a new regional campus in Delaware this year - Bayhealth. Students can now choose to spend their entire 3rd year in Delaware. Just be cautious that it can become more and more difficult to stay in Philadelphia for rotation in the future, and everyone might have to move at some point. It's probably not too bad if you're originally from places like California, Delaware or North Carolina and want to go back for your rotation (it's not too competitive to get a spot at those sites at least this year because most people don't want to move that far.)
Honestly, I think preclinical years at Drexel aren't that different from other MD programs. However, clinical site lottery can be a very stressful process for a lot of us. We just got our lottery results last week, and there are many classmates who didn't get a regional campus spot and have to move every few weeks to rotate between different sites for the third year.
Like Drake mentioned, one of our biggest rotation site in Philadelphia (which takes about 40 students/class), Crozer Health, is looking to sell its hospitals on the market right now. If they can't find a potential buyer by the end of this year, the hospital may be forced to shut down by its parent company, just like what happened to Hahnemann. Our primary clinical partner Tower Health is also struggling financially, and may be sold to private equity if it runs out of cash (it only has 30-day cash in hands right now according to Philadelphia Inquirer - a local newspaper.) Of course, these are not Drexel's faults since Drexel doesn't run any of these hospitals but rather only maintains loose affiliative relationship with them. However, if we do lose either clinical site, it can cause a lot of uncertainties to students, especially if they are shut down or being sold to a third-party in the middle of a rotation.
With that being said, I think admins at COM have realized what's going on at Crozer, which is why they announced a new regional campus in Delaware this year - Bayhealth. Students can now choose to spend their entire 3rd year in Delaware. Just be cautious that it can become more and more difficult to stay in Philadelphia for rotation in the future, and everyone might have to move at some point. It's probably not too bad if you're originally from places like California, Delaware or North Carolina and want to go back for your rotation (it's not too competitive to get a spot at those sites at least this year because most people don't want to move that far.)